Conditioned Pain Modulation in Patients With Hemophilia
Conditions: Hemophilia Interventions: Other: Observational group Sponsors: Investigaci ón en Hemofilia y Fisioterapia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
Blood Flow Restriction in Improving Muscle Strength of Patients With Hemophilic Ankle Arthropathy
Conditions: Hemophilia Interventions: Other: Blood flow restriction Sponsors: Investigaci ón en Hemofilia y Fisioterapia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
Blood Flow Restriction in Improving Muscle Strength of Patients With Hemophilic Knee Arthropathy
Conditions: Hemophilia Interventions: Other: Blood flow restriction Sponsors: Investigaci ón en Hemofilia y Fisioterapia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
Safety and Efficacy Study of NGGT003 in Hemophilia A Patients
Conditions: Hemophilia A Interventions: Drug: NGGT003 Sponsors: Institute of Hematology& Blood Diseases Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
A Study to Learn More About the Safety of Damoctocog-alfa-pegol When Used in Routine Medical Care in Korean Participants With Hemophilia A
Conditions: Hemophilia A; Prophylaxis of Bleeding; Treatment of Bleeding Interventions: Drug: Damoctocog-alfa-pegol (Jivi, BAY94-9027) Sponsors: Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Phase 3 Study for Efficacy and Safety Outcomes Data in Japanese Patients With Severe Hemophilia A
Conditions: Hemophilia A Interventions: Biological: Valoctocogene roxaparvovec Sponsors: BioMarin Pharmaceutical Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Evaluation of the overall haemostatic capacity of mim8 with global haemostasis assays and fibrin clot ultrastructure
Conditions: Hemophilia A Interventions: Other: blood test Sponsors: Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
Canadian CHO-KLAT/H-FIT Study - Quality of Life of, and Burden of Caring for, Persons With Hemophilia
Conditions: Hemophilia Sponsors: The Hospital for Sick Children; Roche Pharma AG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials
A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A
Conditions: Hemophilia A Interventions: Genetic: ANB-010, dose 1; Genetic: ANB-010, dose 2; Genetic: ANB-010, dose 3 Sponsors: Biocad Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2023 Category: Research Source Type: clinical trials
Marstacimab Phase 3 Data Presented at ASH 2023 Demonstrate Significant Bleed Reduction in Hemophilia A and B
Marstacimab reduced annualized bleeding rate by 35% and 92% compared to routine prophylaxis and on-demand treatment in patients with hemophilia A and B without inhibitors, respectively
Consistent reduction in bleeding rates observed after an... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 9, 2023 Category: Pharmaceuticals Source Type: clinical trials
Study of Surgical Practices in Patients With Haemophilia A or B Treated With an Extended Half-life Recombinant Factor VIII-Fc or IX-Fc (ELOCTA ®, ALPROLIX®)
Conditions: Hemophilia A; Hemophilia B Interventions: Drug: Describe the respective haemostatic efficacy of Elocta ® for haemopilia A during surgical procedures; Drug: Describe the respective haemostatic efficacy of Alprolix® for haemopilia B during surgical procedures Sponsors: Hospices Civils de Lyon Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
Comparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia A
Conditions: Severe Hemophilia A Without Inhibitor; Joint Bleed Interventions: Drug: " Emicizumab " , " HEMLIBRA ® " Sponsors: Chulalongkorn University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Conditions: Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including; Sickle Cell Disease; Cystic Fibrosis; Fragile X Syndrome; Proximal Spinal Muscular Atrophy; Myotonic Dystrophy; Muscular Dystrophy, Duchenne; Muscular Dystrophy, Becker; Neurofibromatosis-Noonan Syndrome; Huntington Disease; Hemophilia A; Hemophilia B; MODY2 Diabetes; X-Linked Hydrocephalus; Autosomal Recessive Polycystic Kidney Disease Interventions: Biological: Blood sample Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
Conditions: Hemophilia A Interventions: Drug: Fitusiran (SAR439774); Biological: Clotting factor concentrates (CFC) or bypassing agents (BPA); Biological: Antithrombin concentrate (ATIIIC); Biological: Emicizumab Sponsors: Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)
Conditions: Liver Cirrhosis Interventions: Drug: Foscenvivint Sponsors: Kiminori Kimura, MD; Japan Agency for Medical Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
